BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12058238)

  • 1. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab.
    Hongeng S; Tardtong P; Worapongpaiboon S; Ungkanont A; Jootar S
    Bone Marrow Transplant; 2002 May; 29(10):871-2. PubMed ID: 12058238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome.
    Silvana B; Antonella LM; Basilia P; Trombetta D; Saija A; Salpietro C
    Pediatr Transplant; 2007 Aug; 11(5):552-6. PubMed ID: 17631027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation.
    Drobyski WR; Potluri J; Sauer D; Gottschall JL
    Bone Marrow Transplant; 1996 Jun; 17(6):1093-9. PubMed ID: 8807120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation.
    Horn B; Viele M; Mentzer W; Mogck N; DeSantes K; Cowan M
    Bone Marrow Transplant; 1999 Nov; 24(9):1009-13. PubMed ID: 10556961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases.
    O'Brien TA; Eastlund T; Peters C; Neglia JP; Defor T; Ramsay NK; Scott Baker K
    Br J Haematol; 2004 Oct; 127(1):67-75. PubMed ID: 15384979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rituximab instead of splenectomy in 4 children with chronic or refractory autoimmune haemolytic anaemia].
    van Daalen ST; van Dijken PJ; Tamminga RY; Brons PP
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2350-4. PubMed ID: 16261716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia.
    Seeliger S; Baumann M; Mohr M; Jürgens H; Frosch M; Vormoor J
    Eur J Pediatr; 2001 Aug; 160(8):492-6. PubMed ID: 11548187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
    Perrotta S; Locatelli F; La Manna A; Cennamo L; De Stefano P; Nobili B
    Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.
    De Lord C; Marsh JC; Smith JG; Singer CR; Gordon-Smith EC
    Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant.
    Chen FE; Owen I; Savage D; Roberts I; Apperley J; Goldman JM; Laffan M
    Bone Marrow Transplant; 1997 Mar; 19(5):491-5. PubMed ID: 9052917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab.
    Aglieco F; Manickaratnam S; Bona R; Kaplan AA
    Ther Apher Dial; 2008 Apr; 12(2):185-9. PubMed ID: 18387171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
    Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
    Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions.
    Cwynarski K; Goulding R; Pocock C; Dazzi F; Craddock C; Kaeda J; Olavarria E; Kanfer E; Apperley J; Lawler M; Goldman JM
    Bone Marrow Transplant; 2001 Sep; 28(6):581-6. PubMed ID: 11607771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
    Radhi M; Rumelhart S; Tatman D; Goldman F
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for refractory childhood autoimmune hemolytic anemia.
    Motto DG; Williams JA; Boxer LA
    Isr Med Assoc J; 2002 Nov; 4(11):1006-8. PubMed ID: 12489491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient.
    Endo T; Nakao S; Koizumi K; Nishio M; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
    Ann Hematol; 2004 Feb; 83(2):114-6. PubMed ID: 14513283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood refractory autoimmune haemolytic anaemia: is there a role for anti-CD20 therapy (rituximab)?
    McMahon C; Babu L; Hodgson A; Hayat A; Connell NO; Smith OP
    Br J Haematol; 2002 May; 117(2):480-3. PubMed ID: 11972537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.